The news microarrays profiles of NSCLC relapse risks will :

• assessing the risk of relapse in patients undergoing resection of NSCLC (by knowing this risk, patients at highest risk of relapse would be treated as a priority, while avoiding treating patients with low risk)
• assessing the risk of chemo-resistant tumor cells characters to optimize the choice of treatment to offer to the patient
• assessing the prediction of sites most likely metastatic relapse to guide survey strategy.

The news microarrays profiles of NSCLC relapse risks will :

• assessing the risk of relapse in patients undergoing resection of NSCLC (by knowing this risk, patients at highest risk of relapse would be treated as a priority, while avoiding treating patients with low risk)
• assessing the risk of chemo-resistant tumor cells characters to optimize the choice of treatment to offer to the patient
• assessing the prediction of sites most likely metastatic relapse to guide survey strategy.

The news microarrays profiles of NSCLC relapse risks will :

• assessing the risk of relapse in patients undergoing resection of NSCLC (by knowing this risk, patients at highest risk of relapse would be treated as a priority, while avoiding treating patients with low risk)
• assessing the risk of chemo-resistant tumor cells characters to optimize the choice of treatment to offer to the patient
• assessing the prediction of sites most likely metastatic relapse to guide survey strategy.

The news microarrays profiles of NSCLC relapse risks will :

• assessing the risk of relapse in patients undergoing resection of NSCLC (by knowing this risk, patients at highest risk of relapse would be treated as a priority, while avoiding treating patients with low risk)
• assessing the risk of chemo-resistant tumor cells characters to optimize the choice of treatment to offer to the patient
• assessing the prediction of sites most likely metastatic relapse to guide survey strategy.

The news microarrays profiles of NSCLC relapse risks will :

• assessing the risk of relapse in patients undergoing resection of NSCLC (by knowing this risk, patients at highest risk of relapse would be treated as a priority, while avoiding treating patients with low risk)
• assessing the risk of chemo-resistant tumor cells characters to optimize the choice of treatment to offer to the patient
• assessing the prediction of sites most likely metastatic relapse to guide survey strategy.

The news microarrays profiles of NSCLC relapse risks will :

• assessing the risk of relapse in patients undergoing resection of NSCLC (by knowing this risk, patients at highest risk of relapse would be treated as a priority, while avoiding treating patients with low risk)
• assessing the risk of chemo-resistant tumor cells characters to optimize the choice of treatment to offer to the patient
• assessing the prediction of sites most likely metastatic relapse to guide survey strategy.

The news microarrays profiles of NSCLC relapse risks will :

• assessing the risk of relapse in patients undergoing resection of NSCLC (by knowing this risk, patients at highest risk of relapse would be treated as a priority, while avoiding treating patients with low risk)
• assessing the risk of chemo-resistant tumor cells characters to optimize the choice of treatment to offer to the patient
• assessing the prediction of sites most likely metastatic relapse to guide survey strategy.